Junction Bioscience
YC W24New York City, US · Founded 2024 · 1 known investors
Junction Bioscience develops AI-driven software that generates and tests scientific hypotheses to discover new drug candidates, with an initial focus on therapies targeting neuroinflammatory and immunological diseases.
Founders & leadership· Y Combinator alumni (W24)
Brian PetkovinFounder